Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 396

    1.

    Prostate Cancer Screening with Prostate-Specific Antigen Testing: More Answers or More Confusion?

    Diamandis EP, Walsh PC, Jung K, Catalona WJ, Fleshner N.

    Clin Chem. 2010 Jan 21. [Epub ahead of print] No abstract available. PMID: 20093554 [PubMed - as supplied by publisher]Related articles

    2.

    Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance Protocols.

    Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ.

    Urology. 2009 Dec 4. [Epub ahead of print]PMID: 19963249 [PubMed - as supplied by publisher]Related articles

    3.

    Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?

    Loeb S, Roehl KA, Helfand BT, Kan D, Catalona WJ.

    J Urol. 2010 Jan;183(1):112-6. Epub .PMID: 19913814 [PubMed - indexed for MEDLINE]Related articles

    4.

    Is statin use associated with prostate cancer aggressiveness?

    Loeb S, Kan D, Helfand BT, Nadler RB, Catalona WJ.

    BJU Int. 2009 Nov 3. [Epub ahead of print]PMID: 19888973 [PubMed - as supplied by publisher]Related articles

    5.

    Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures.

    Carvalhal GF, Griffin CR, Kan D, Loeb S, Catalona WJ.

    BJU Int. 2009 Nov 3. [Epub ahead of print]PMID: 19888968 [PubMed - as supplied by publisher]Related articles

    6.

    Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.

    Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, Stacey SN, Sigurdsson A, Wahlfors T, Tammela T, Breyer JP, McReynolds KM, Bradley KM, Saez B, Godino J, Navarrete S, Fuertes F, Murillo L, Polo E, Aben KK, van Oort IM, Suarez BK, Helfand BT, Kan D, Zanon C, Frigge ML, Kristjansson K, Gulcher JR, Einarsson GV, Jonsson E, Catalona WJ, Mayordomo JI, Kiemeney LA, Smith JR, Schleutker J, Barkardottir RB, Kong A, Thorsteinsdottir U, Rafnar T, Stefansson K.

    Nat Genet. 2009 Oct;41(10):1122-6. Epub 2009 Sep 20.PMID: 19767754 [PubMed - indexed for MEDLINE]Related articles

    7.

    Editorial comment.

    Catalona WJ.

    J Urol. 2009 Nov;182(5):2278-9; discussion 2279. Epub 2009 Sep 16. No abstract available. PMID: 19758652 [PubMed - indexed for MEDLINE]Related articles

    8.

    Editorial comment.

    Catalona WJ.

    Urology. 2009 Sep;74(3):624-5. No abstract available. PMID: 19716918 [PubMed - indexed for MEDLINE]Related articles

    9.

    MEK4 function, genistein treatment, and invasion of human prostate cancer cells.

    Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B, Wellman K, Killmer J, Huang X, Scheidt KA, Montgomery RB, Bergan RC.

    J Natl Cancer Inst. 2009 Aug 19;101(16):1141-55. Epub 2009 Jul 28.PMID: 19638505 [PubMed - indexed for MEDLINE]Related articles

    10.

    20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centers.

    Stephan C, Bangma C, Vignati G, Bartsch G, Lein M, Jung K, Philippe M, Semjonow A, Catalona WJ.

    Int J Biol Markers. 2009 Apr-Jun;24(2):65-9.PMID: 19634108 [PubMed - indexed for MEDLINE]Related articles

    11.

    Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?

    Loeb S, Helfand BT, Kan D, Isaacs WB, Catalona WJ.

    BJU Int. 2009 Nov;104(9):1200-3. Epub 2009 Jul 20.PMID: 19627283 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prostate-cancer screening.

    Catalona WJ.

    N Engl J Med. 2009 Jul 9;361(2):202; author reply 204-5. No abstract available. PMID: 19587348 [PubMed - indexed for MEDLINE]Related articles

    13.

    Bladder neck contracture after retropubic radical prostatectomy: incidence and risk factors from a large single-surgeon experience.

    Erickson BA, Meeks JJ, Roehl KA, Gonzalez CM, Catalona WJ.

    BJU Int. 2009 Dec;104(11):1615-9. Epub 2009 Jul 2.PMID: 19583720 [PubMed - in process]Related articles

    14.

    Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.

    Pal P, Xi H, Guha S, Sun G, Helfand BT, Meeks JJ, Suarez BK, Catalona WJ, Deka R.

    Prostate. 2009 Oct 1;69(14):1548-56.PMID: 19562729 [PubMed - indexed for MEDLINE]Related articles

    15.

    Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.

    Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.

    Clin Cancer Res. 2009 May 15;15(10):3557-67. Epub 2009 May 15.PMID: 19447876 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pathological outcomes associated with the 17q prostate cancer risk variants.

    Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ.

    J Urol. 2009 Jun;181(6):2502-7. Epub 2009 Apr 16.PMID: 19371897 [PubMed - indexed for MEDLINE]Related articles

    17.

    Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml.

    Meeks JJ, Loeb S, Helfand BT, Kan D, Smith ND, Catalona WJ.

    J Urol. 2009 Jun;181(6):2515-8; discussion 2518-9. Epub 2009 Apr 16.PMID: 19371879 [PubMed - indexed for MEDLINE]Related articles

    18.

    Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease.

    Helfand BT, Mongiu AK, Kan D, Kim DY, Loeb S, Roehl KA, Meeks JJ, Smith ND, Catalona WJ.

    BJU Int. 2009 Aug;104(3):304-9. Epub 2009 Feb 23.PMID: 19239451 [PubMed - indexed for MEDLINE]Related articles

    19.

    Diagnosis and treatment of prostate cancer. Beyond the controversy over whether and whom to screen, the appropriate method of screening is also subject to debate.

    Loeb S, Catalona WJ.

    Med Econ. 2008 Dec 19;85(24):36-41. No abstract available. PMID: 19209648 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.

    Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, Blöndal T, Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Ragnarsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K, Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Matthiasdottir S, Sveinsdottir SG, Polidoro S, Höiom V, Botella-Estrada R, Hemminki K, Rudnai P, Bishop DT, Campagna M, Kellen E, Zeegers MP, de Verdier P, Ferrer A, Isla D, Vidal MJ, Andres R, Saez B, Juberias P, Banzo J, Navarrete S, Tres A, Kan D, Lindblom A, Gurzau E, Koppova K, de Vegt F, Schalken JA, van der Heijden HF, Smit HJ, Termeer RA, Oosterwijk E, van Hooij O, Nagore E, Porru S, Steineck G, Hansson J, Buntinx F, Catalona WJ, Matullo G, Vineis P, Kiltie AE, Mayordomo JI, Kumar R, Kiemeney LA, Frigge ML, Jonsson T, Saemundsson H, Barkardottir RB, Jonsson E, Jonsson S, Olafsson JH, Gulcher JR, Masson G, Gudbjartsson DF, Kong A, Thorsteinsdottir U, Stefansson K.

    Nat Genet. 2009 Feb;41(2):221-7. Epub 2009 Jan 18.PMID: 19151717 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...